KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Times Interest Earned: 2009-2025

Historic Times Interest Earned for Neogenomics (NEO) over the last 10 years, with Sep 2025 value amounting to -$44.80.

  • Neogenomics' Times Interest Earned fell 247.03% to -$44.80 in Q3 2025 from the same period last year, while for Sep 2025 it was -$25.30, marking a year-over-year decrease of 82.96%. This contributed to the annual value of -$13.92 for FY2024, which is 10.76% up from last year.
  • Latest data reveals that Neogenomics reported Times Interest Earned of -$44.80 as of Q3 2025, which was up 12.24% from -$51.05 recorded in Q2 2025.
  • Neogenomics' 5-year Times Interest Earned high stood at -$5.06 for Q4 2022, and its period low was -$284.24 during Q3 2022.
  • For the 3-year period, Neogenomics' Times Interest Earned averaged around -$20.97, with its median value being -$16.76 (2023).
  • Its Times Interest Earned has fluctuated over the past 5 years, first tumbled by 1,713.19% in 2021, then skyrocketed by 94.95% in 2023.
  • Quarterly analysis of 5 years shows Neogenomics' Times Interest Earned stood at -$8.58 in 2021, then soared by 41.03% to -$5.06 in 2022, then plummeted by 118.41% to -$11.05 in 2023, then decreased by 2.55% to -$11.33 in 2024, then slumped by 247.03% to -$44.80 in 2025.
  • Its last three reported values are -$44.80 in Q3 2025, -$51.05 for Q2 2025, and -$17.20 during Q1 2025.